HEPATITIS B, CHRONIC
Clinical trials for HEPATITIS B, CHRONIC explained in plain language.
Never miss a new study
Get alerted when new HEPATITIS B, CHRONIC trials appear
Sign up with your email to follow new studies for HEPATITIS B, CHRONIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New vaccine aims to control hepatitis b in patients on standard treatment
Disease control TerminatedThis study tested a new therapeutic vaccine (GSK3528869A) in adults aged 18-65 with chronic hepatitis B whose virus was already well-controlled by standard antiviral pills. The goal was to see if the vaccine could further reduce virus levels and improve the immune response. The t…
Matched conditions: HEPATITIS B, CHRONIC
Phase: PHASE1, PHASE2 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated May 17, 2026 05:08 UTC
-
Experimental hepatitis b drug shows promise but study halted
Disease control TerminatedThis study tested an experimental drug called ARC-520, given with a standard antiviral (entecavir), to lower hepatitis B surface antigen levels in people with chronic hepatitis B. The trial included 58 participants and was stopped early. The goal was to control the virus, not cur…
Matched conditions: HEPATITIS B, CHRONIC
Phase: PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 05:08 UTC
-
New vaccine aims to tame hepatitis b without lifelong drugs
Disease control TerminatedThis study tested a vaccine called HepTcell in 87 adults with inactive chronic hepatitis B who had low levels of the virus. The goal was to see if the vaccine could lower hepatitis B surface antigen (HBsAg) or clear it from the blood. The study was stopped early, so results are l…
Matched conditions: HEPATITIS B, CHRONIC
Phase: PHASE2 • Sponsor: Altimmune, Inc. • Aim: Disease control
Last updated May 14, 2026 12:06 UTC